Latest filing published 27 Sept 2024 for Dr. Lal Path Labs Ltd., €67k.
Filing timeline
BuySaleMridula Paliwal: trading record in brief
This profile gathers the share dealings of Mridula Paliwal in Dr. Lal Path Labs Ltd. Over a trading history stretching from 24 March 2022 to 25 September 2024, the count stands at 2 filings.
In open-market terms, that means 1 purchase worth €117k on one side and 1 sale worth €67k on the other. The net balance comes to €50k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings no purchases and 1 sale.
On 27 September 2024 came the latest disclosure, an open-market sale for €67k in Dr. Lal Path Labs Ltd. The latest purchase dates back some time: it was published 1,689 days ago, on 25 March 2022. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mridula Paliwal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,850 shares@ ₹3,350.0036.3% of flowEquity SharesSEBI:a8cffc52fc8ddc0674563b1a60444eb575077cb9
- 3,700 shares@ ₹2,664.982763.7% of flowEquity SharesSEBI:cecc66f03582e7e9862d9bcf035bf3287e5c5f22Canonical exit: 22 Jun 2022 (T+90)
2 of 2 declarations
